Agios Pharmaceuticals (AGIO) Stock: Buy, Sell, or Hold?
$31.76
+0.38 (+1.21%)
▲
5d:
+1.79%
30d:
+3.05%
90d:
-7.16%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
45/100
Position
OVERSOLD
30-Day Fair Range
$30.42 – $35.99
Position: OVERSOLD
Forward P/E & Valuation
-10.1x
Next 12M consensus est.
Wall Street Target
$46.50
+46.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$27.57 / $38.69
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: AGIO shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When AGIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: AGIO is currently trading at $31.76, which is considered oversold relative to its 30-day fair value range of $30.42 to $35.99.
Technical Outlook: Technically, AGIO is in a downtrend. Immediate support is located at $27.57, while resistance sits at $38.69.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $46.50 (+46.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AGIO is in a downtrend. Immediate support is located at $27.57, while resistance sits at $38.69.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $46.50 (+46.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$30.42 -
$35.99
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$30.42 -
$35.99
Current vs Trading Range
OVERSOLD
Support Level
$27.57
Resistance Level
$38.69
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.4% below Wall St target ($46.50)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-10.08
Wall Street Target
$46.50
(+46.4%)
Revenue Growth (YoY)
330.0%
Profit Margin
-264.8%
Share AGIO Analysis
Share this live AGIO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AGIO)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Agios Pharmaceuticals (AGIO) reported Q3 earnings, beating revenue estimates and posting a smaller loss than expected, driving bullish sentiment on StockTwits.
Key Retail Themes:
Q3 earnings beat
Revenue surpassing estimates
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 10:06 PM ET
Data refreshes hourly during market hours. Next update: 11:06 PM
Data refreshes hourly during market hours. Next update: 11:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 60 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 53 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AGIO Research Pages
